CLC Policy Issues: FDA


	Home \| Sitemap \| Contact Info

	Clinical Trials—Medicare \| Clinical Trials—Private Insurance \| Medicare Payment FDA \| Cancer Research \| Stem Cell Research \| Privacy \| Other


		December 2, 2019 The Honorable Lamar Alexander Chairman HELP Committee United States Senate Washington, DC 20510 The Honorable Patty Murray Ranking Member HELP Committee United States Senate Washington, DC 20510 Dear Chairman Alexander and Ranking Member Murray: The undersigned cancer organizations, including patient organizations, professional societies, and research foundations, are writing to express support for the nomination of Dr. Stephen Hahn to be the Commissioner of the Food and Drug Administration (FDA). Some of us have worked with Dr. Hahn for years as a result of his volunteer leadership of cancer organizations, and others have more recently become acquainted with him. We all support him because of his focus on patients, commitment to public health, and pledge to honor science-based decision-making. His record in cancer clinical care, clinical research, and institutional leadership prepares him well to lead FDA. We are especially concerned about attracting and retaining a stellar FDA staff, and we believe that Dr. Hahn can provide leadership on FDA staffing matters. Because of the significant responsibilities of FDA, there is never a time that the agency does not face challenges. However, the agency currently confronts an especially daunting agenda, including regulation of increasingly complex therapies, addressing the teen vaping epidemic, contributing to efforts to address the opioid epidemic, and maintaining an outstanding staff to manage these issues. We trust Dr. Hahn to lead the agency through these challenges. Sincerely, Cancer Leadership Council American Society for Radiation Oncology American Society of Clinical Oncology CancerCare Children’s Cancer Cause Fight Colorectal Cancer International Myeloma Foundation LUNGevity Foundation Lymphoma Research Foundation National Coalition for Cancer Survivorship National Comprehensive Cancer Network Ovarian Cancer Research Alliance Prevent Cancer Foundation Sarcoma Foundation of America Susan G. Komen cc: HELP Committee Members Back to FDA Index About CLC \| What's New \| Policy Issues \| Participants' Login Home \| Sitemap \| Contact Info Copyright © 2001-2002 Cancer Leadership Council. All rights reserved. Please send comments and suggestions to webmaster@cancerleadership.org.